0001209191-21-005492.txt : 20210126
0001209191-21-005492.hdr.sgml : 20210126
20210126182019
ACCESSION NUMBER: 0001209191-21-005492
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210125
FILED AS OF DATE: 20210126
DATE AS OF CHANGE: 20210126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dentzer James E
CENTRAL INDEX KEY: 0001400977
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30347
FILM NUMBER: 21555785
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 6 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CURIS INC
CENTRAL INDEX KEY: 0001108205
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043505116
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 128 SPRING STREET
STREET 2: BUILDING C, SUITE 500
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617-503-6500
MAIL ADDRESS:
STREET 1: 128 SPRING STREET
STREET 2: BUILDING C, SUITE 500
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-25
0
0001108205
CURIS INC
CRIS
0001400977
Dentzer James E
C/O CURIS, INC.
128 SPRING STREET BUILDING C SUITE 500
LEXINGTON
MA
02421
1
1
0
0
President & CEO
Common Stock
2021-01-25
4
S
0
2283
10.96
D
70362
D
Common Stock
2021-01-26
4
S
0
3094
10.5876
D
67268
D
Shares were sold pursuant to a "sell to cover" arrangement to satisfy minimum statutory tax withholding obligations related to a vesting of a service-based restricted stock award granted on January 22, 2018.
This transaction was effected pursuant to Rule 10b5-1 trading plans to cover tax obligations.
William Steinkrauss, attorney-in-fact
2021-01-26